Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ.

Lancet. 1999 Mar 6;353(9155):797-801.

PMID:
10459961
2.

Radionuclide therapy of hepatocellular carcinoma.

Keng GH, Sundram FX.

Ann Acad Med Singapore. 2003 Jul;32(4):518-24. Review.

PMID:
12968558
3.

131-iodine Lipiodol therapy in hepatocellular carcinoma.

Raoul JL, Boucher E, Roland V, Garin E.

Q J Nucl Med Mol Imaging. 2009 Jun;53(3):348-55. Review.

4.

Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma.

Furtado R, Crawford M, Sandroussi C.

Ann Surg Oncol. 2014 Aug;21(8):2700-7. doi: 10.1245/s10434-014-3511-2. Epub 2014 Apr 18. Review.

PMID:
24743904
5.

Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.

Bhattacharya S, Dusheiko GM.

Princess Takamatsu Symp. 1995;25:253-64. Review.

PMID:
8875631
6.

Treatment of hepatocellular carcinoma by means of radiopharmaceuticals.

Lambert B, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):980-9. Review.

PMID:
16032439

Supplemental Content

Support Center